Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Kern H et al. Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group. 1998 Biochim. Biophys. Acta pmid:9767093
Bozza PT et al. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. 1998 J. Leukoc. Biol. pmid:9766638
Marriott I et al. Differential kinetics for induction of interleukin-6 mRNA expression in murine peritoneal macrophages: evidence for calcium-dependent and independent-signalling pathways. 1998 J. Cell. Physiol. pmid:9766520
Kabasakal C et al. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis. 1998 Jul-Sep Turk. J. Pediatr. pmid:9763906
Spoelstra FM et al. Effect of theophylline on CD11b and L-selectin expression and density of eosinophils and neutrophils in vitro. 1998 Eur. Respir. J. pmid:9762784
Tamm M et al. Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9761763
Kinn JW and Bache RJ Effect of platelet activation on coronary collateral blood flow. 1998 Circulation pmid:9760298
El-Shazly A et al. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils. 1998 Int. Arch. Allergy Immunol. pmid:9758899
Matsumoto K et al. Altered expression of CD11b and CD62L after cross-linking of CD45 isoforms on human eosinophils. 1998 Int. Arch. Allergy Immunol. pmid:9758894
El-Shazly A et al. Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate. 1998 Int. Arch. Allergy Immunol. pmid:9758889
Heath MF et al. Dextran-70 inhibits equine platelet aggregation induced by PAF but not by other agonists. 1998 Equine Vet. J. pmid:9758098
Endo S et al. Administration of methylprednisolone acetate into the subdural cavity in an infant with subdural fluid collection. PAF is a good indicator of the efficacy of the treatment. 1998 Childs Nerv Syst pmid:9753399
Rocha MF et al. Intestinal secretory factor released by macrophages stimulated with Clostridium difficile toxin A: role of interleukin 1beta. 1998 Infect. Immun. pmid:9746596
Huang Q et al. Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles. 1998 Am. J. Physiol. pmid:9746460
Kruse-Elliott KT et al. Low molecular weight heparin alters porcine neutrophil responses to platelet-activating factor. 1998 Shock pmid:9744648
Liu L et al. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator. 1998 J. Immunol. pmid:9743372
Cheryk LA et al. Alterations in blood platelet morphology during aggregate formation in the Asian elephant (Elephas maximus). 1998 J. Zoo Wildl. Med. pmid:9732033
M'Rabet L et al. Activation of the small GTPase rap1 in human neutrophils. 1998 Blood pmid:9731072
Burke-Gaffney A and Hellewell PG A CD18/ICAM-1-dependent pathway mediates eosinophil adhesion to human bronchial epithelial cells. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9730868
Ueno M et al. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen. 1998 Pharmacology pmid:9730778